When was Ajax Therapeutics's last funding round?

Ajax Therapeutics's most recent recorded round was Later Stage VC (Series C) in May 2024, raising $95.0M.

PrivateMarketView

How much has Ajax Therapeutics raised?

$143.0Macross 3 recorded rounds · Jun 2019 – May 2024

Most recently, Ajax Therapeutics raised $95.0M in its Later Stage VC (Series C) (May 2024).

Free account

More of Ajax Therapeutics with a free account

No card required

Membership and data by Private Market View

3 rounds

May 2024Later Stage VC (Series C)$95.0M▮

+ 1 more investors · free account

May 2021Early Stage VC$37.4MSEC filing▮

14 investors participated

Jun 2019Early Stage VC$8.0MSEC filing▮

6 investors participated

Ajax Therapeutics has raised $143 million across 3 recorded rounds since 2019. The largest was a $95 million Series C in May 2024.

Ajax Therapeutics has filed 3 Form Ds with the SEC since 2019, most recently in May 2024 ($95 million sold to 21 investors).

11 investors are on record for Ajax Therapeutics, including RA Capital Management, Point72 Ventures, Goldman Sachs Asset Management and Vivo Capital. The Series C in May 2024 drew 8 investors.

For fundraisers

Raising for a company like Ajax Therapeutics?

11 investors have backed Ajax Therapeutics — start your target list with the firms already writing checks in drug discovery.

How much has Ajax Therapeutics raised?: Ajax Therapeutics has raised $143.0M in total across 3 recorded funding rounds.
When was Ajax Therapeutics's last funding round?: Ajax Therapeutics's most recent recorded round was Later Stage VC (Series C) in May 2024, raising $95.0M.